Age-Related Changes in Plasma Concentrations of the HIV Protease Inhibitor Lopinavir

The advent of highly active antiretroviral therapy in the treatment of HIV disease has substantially extended the lifespan of individuals infected with HIV resulting in a growing population of older HIV-infected individuals. The efficacy and safety of antiretroviral agents in the population are impo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS research and human retroviruses 2010-06, Vol.26 (6), p.635-643
Hauptverfasser:	CRAWFORD, Keith W, SPRITZLER, John, KALAYJIAN, Robert C, PARSONS, Teresa, LANDAY, Alan, POLLARD, Richard, STOCKER, Vicki, LEDERMAN, Michael M, FLEXNER, Charles
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Age Factors Aged AIDS (Disease) Anti-HIV Agents - administration & dosage Anti-HIV Agents - adverse effects Anti-HIV Agents - pharmacokinetics Antiretroviral Therapy, Highly Active - methods Biological and medical sciences Blood plasma Clinical Trials/Clinical Studies Development and progression Diagnosis Drug therapy Female Fundamental and applied biological sciences. Psychology Health aspects Highly active antiretroviral therapy HIV (Viruses) HIV Infections - drug therapy HIV Protease Inhibitors - administration & dosage HIV Protease Inhibitors - adverse effects HIV Protease Inhibitors - pharmacokinetics Human immunodeficiency virus Human viral diseases Humans Infectious diseases Lopinavir Male Medical sciences Microbiology Middle Aged Miscellaneous Physiological aspects Plasma - chemistry Prognosis Pyrimidinones - administration & dosage Pyrimidinones - adverse effects Pyrimidinones - pharmacokinetics Retrovirus Risk factors Viral diseases Virology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!